PortfoliosLab logoPortfoliosLab logo
CLOV vs. RELY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CLOV vs. RELY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Clover Health Investments, Corp. (CLOV) and Remitly Global, Inc. (RELY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CLOV achieves a 66.81% return, which is significantly higher than RELY's 33.70% return.


CLOV

1D
2.35%
1M
25.64%
YTD
66.81%
6M
53.13%
1Y
28.31%
3Y*
57.67%
5Y*
-25.36%
10Y*

RELY

1D
-1.70%
1M
-23.22%
YTD
33.70%
6M
36.57%
1Y
-14.35%
3Y*
-1.32%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

CLOV vs. RELY - Yearly Performance Comparison


2026 (YTD)20252024202320222021
CLOV
Clover Health Investments, Corp.
66.81%-25.40%230.85%2.43%-75.01%-52.91%
RELY
Remitly Global, Inc.
33.70%-38.86%16.22%69.61%-44.47%-57.44%

Correlation

The correlation between CLOV and RELY is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.29

Correlation (3Y)
Calculated over the trailing 3-year period

0.22

Correlation (All Time)
Calculated using the full available price history since Sep 24, 2021

0.36

The correlation between CLOV and RELY shifts across timeframes, from 0.22 (3 years) to 0.36 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

CLOV:

$2.05B

RELY:

$4.00B

EPS

CLOV:

-$0.11

RELY:

$0.49

PS Ratio

CLOV:

0.91

RELY:

2.32

PB Ratio

CLOV:

6.03

RELY:

4.41

Total Revenue (TTM)

CLOV:

$2.21B

RELY:

$1.73B

Gross Profit (TTM)

CLOV:

$939.14M

RELY:

$753.03M

EBITDA (TTM)

CLOV:

-$55.21M

RELY:

$142.85M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CLOV vs. RELY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLOV
CLOV Risk / Return Rank: 5656
Overall Rank
CLOV Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
CLOV Sortino Ratio Rank: 5757
Sortino Ratio Rank
CLOV Omega Ratio Rank: 5757
Omega Ratio Rank
CLOV Calmar Ratio Rank: 5555
Calmar Ratio Rank
CLOV Martin Ratio Rank: 5252
Martin Ratio Rank

RELY
RELY Risk / Return Rank: 3131
Overall Rank
RELY Sharpe Ratio Rank: 3131
Sharpe Ratio Rank
RELY Sortino Ratio Rank: 3131
Sortino Ratio Rank
RELY Omega Ratio Rank: 3131
Omega Ratio Rank
RELY Calmar Ratio Rank: 3131
Calmar Ratio Rank
RELY Martin Ratio Rank: 3131
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CLOV vs. RELY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and Remitly Global, Inc. (RELY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CLOVRELYDifference
Sharpe ratioReturn per unit of total volatility

+0.67

Sortino ratioReturn per unit of downside risk

+1.08

Omega ratioGain probability vs. loss probability

1.14

1.00

+0.14

Calmar ratioReturn relative to maximum drawdown

0.51

-0.35

+0.86

Martin ratioReturn relative to average drawdown

0.93

-0.63

+1.56

CLOV vs. RELY - Sharpe Ratio Comparison

The current CLOV Sharpe Ratio is 0.41, which is higher than the RELY Sharpe Ratio of -0.26. The chart below compares the historical Sharpe Ratios of CLOV and RELY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CLOVRELYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.41

-0.26

+0.67

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.33

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.17

-0.32

+0.14

Drawdowns

CLOV vs. RELY - Drawdown Comparison

The maximum CLOV drawdown since its inception was -97.19%, which is greater than RELY's maximum drawdown of -85.80%. Use the drawdown chart below to compare losses from any high point for CLOV and RELY.


Loading charts...

Drawdown Indicators


CLOVRELYDifference

Max Drawdown

Largest peak-to-trough decline

-97.19%

-85.80%

-11.39%

Max Drawdown (1Y)

Largest decline over 1 year

-55.50%

-40.89%

-14.61%

Max Drawdown (3Y)

Largest decline over 3 years

-64.73%

-57.92%

-6.81%

Max Drawdown (5Y)

Largest decline over 5 years

-95.86%

Current Drawdown

Current decline from peak

-82.30%

-61.92%

-20.38%

Average Drawdown

Average peak-to-trough decline

-76.63%

-64.50%

-12.13%

Ulcer Index

Depth and duration of drawdowns from previous peaks

30.48%

25.50%

+4.98%

Volatility

CLOV vs. RELY - Volatility Comparison

Clover Health Investments, Corp. (CLOV) has a higher volatility of 23.92% compared to Remitly Global, Inc. (RELY) at 13.97%. This indicates that CLOV's price experiences larger fluctuations and is considered to be riskier than RELY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CLOVRELYDifference

Volatility (1M)

Calculated over the trailing 1-month period

23.92%

13.97%

+9.95%

Volatility (6M)

Calculated over the trailing 6-month period

40.34%

38.48%

+1.86%

Volatility (1Y)

Calculated over the trailing 1-year period

69.47%

55.84%

+13.63%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

78.08%

59.08%

+19.00%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

85.65%

59.08%

+26.57%

Dividends

CLOV vs. RELY - Dividend Comparison

Neither CLOV nor RELY has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CLOV vs. RELY - Financials Comparison

This section allows you to compare key financial metrics between Clover Health Investments, Corp. and Remitly Global, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M20222023202420252026
749.19M
452.80M
(CLOV) Total Revenue
(RELY) Total Revenue
Values in USD except per share items

CLOV vs. RELY - Profitability Comparison

The chart below illustrates the profitability comparison between Clover Health Investments, Corp. and Remitly Global, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-20.0%0.0%20.0%40.0%60.0%80.0%100.0%20222023202420252026
92.4%
0
Portfolio components
CLOV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a gross profit of 692.13M and revenue of 749.19M. Therefore, the gross margin over that period was 92.4%.

RELY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Remitly Global, Inc. reported a gross profit of 0.00 and revenue of 452.80M. Therefore, the gross margin over that period was 0.0%.

CLOV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported an operating income of 27.33M and revenue of 749.19M, resulting in an operating margin of 3.7%.

RELY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Remitly Global, Inc. reported an operating income of 53.74M and revenue of 452.80M, resulting in an operating margin of 11.9%.

CLOV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a net income of 27.33M and revenue of 749.19M, resulting in a net margin of 3.7%.

RELY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Remitly Global, Inc. reported a net income of 49.05M and revenue of 452.80M, resulting in a net margin of 10.8%.


Frequently Asked Questions


CLOV and RELY have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CLOV has higher volatility (23.92%) compared to RELY (13.97%). In terms of maximum drawdown, CLOV dropped -97.19% vs RELY's -85.80%.

CLOV currently has the higher Sharpe Ratio (0.41 vs -0.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CLOV and RELY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer